Create Alert
Watchlist

Kilitch Drugs (India)

₹341.50
+0.65 (0.19%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
342.55
Prev. Close
340.85
Volume
7,135
Total traded value
0.24 Cr
Upper Circuit
409.00
Lower Circuit
272.70

Fundamentals

Market Cap₹597Cr
ROE10.38%
P/E Ratio(TTM)22.86
EPS(TTM)14.95
P/B Ratio2.25
Dividend Yield0.00%
Industry P/E33.35
Book Value151.97
Debt to Equity0.31
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Kilitch Drugs (india) Limited.

Kilitch Drugs (India) Limited is one of the world's leading and fastest-growing pharmaceutical companies, manufacturing and supplying a broad range of formulations globally. The company embraces purpose-driven leadership to create long-term value beyond financial performance, establishing itself as a significant entity in the pharmaceutical industry. It is committed to achieving sustainable healthcare by optimizing its processes and practices through continuous innovation and sustainable operations. Its extensive research has developed a diverse portfolio targeting chronic and acute treatments, including injectables, ophthalmics, effervescent tablets, and nutraceuticals. With a formidable presence across Asia, Africa, CIS, and Latin America, the company offers a broad product portfolio to suit each country's needs. A key international asset is its Ethiopia Unit, the largest Cephalosporin plant in East Africa, producing tablets, capsules, and injectables.;
Parent OrganisationKilitch Drugs (india) Limited.
Managing DirectorMukund Mehta
Founded1992
NSE SymbolKILITCH

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
63.77%
Retail And Others
36.23%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
58.80
Ajanta Pharma
NA
(0.00%)
33.44
Gland Pharma
NA
(0.00%)
36.89
Eris Lifesciences
NA
(0.00%)
47.39